Resource Directory

Some pharmaceutical companies offer prescription drug programs to make specific drugs available to people who could not otherwise afford them. Generally, your doctor must apply to these programs on your behalf. However, you can call and obtain the applications and information to help speed the process. Eligibility requirements and program operations vary greatly from one program to another.

Following are listings of pharmaceutical company patient assistance programs for some of the drugs commonly used by people with lung cancer.

Amgen, Inc.
Amgen’s patient assistance programs are a continuum of services designed to provide access through free goods and other support services to qualifying uninsured and underinsured patients. In addition, Amgen makes donations to third-party co-pay assistance foundations. To enroll, please call the appropriate hotline number listed below.
Telephone: 1-800-272-9376 (nephrology)
1-888-427-7478 (oncology)
1-888-762-6436 (The Safety Net Foundation)

AstraZeneca
AZ&ME Prescription Savings Program. Helping patients access their AstraZeneca medicines
Telephone: 1-800-AZandME
https://www.azandmeapp.com/

Bayer Corporation
The Bayer Healthcare Pharmaceuticals patient assistance program offers free medication to people who otherwise cannot afford their medications. Patients must meet financial and other program specific criteria to be eligible for assistance. To find out how to apply for medication assistance register for free.
www.rxassist.org/pap-info/company-detail?CmpId=7

Boehringer Ingelheim Patient Assistance Program
The BI Cares Patient Assistance Program is a charitable program provided by the Boehringer Ingelheim Cares Foundation (BI Cares), an independent nonprofit organization, to improve patients’ health and lives. The program provides Boehringer Ingelheim medicines free of charge to uninsured and underinsured US patients who meet our eligibility requirements.
https://www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program

Bristol-Myers Squibb Company
The Bristol-Myers Squibb Patient Assistance Foundation, Inc. is a non-profit organization. The Foundation was established in 1998 to provide temporary assistance to qualifying patients with a financial hardship who generally have no private prescription drug insurance and are not enrolled in a prescription drug coverage plan through Medicaid or any other federal, state, or local health program.
Telephone: 1-800-736-0003
www.bmspaf.org/

Eli Lilly and Company – Lilly Oncology
For Gemzar® and Alimta®, Lilly provides assistance with obtaining reimbursement. If patients do not have insurance and are unable to obtain other financial assistance, they may be eligible to obtain Lilly oncology products through the patient assistance program. For information about obtaining reimbursement assistance and patient assistance, visit:
LillyPatientOne: www.lillypatientone.com/patient/index.html

Celgene
Celgene Patient Support® can help you and your loved ones understand the programs and services available to you.
https://celgenepatientsupport.com/

Genentech, Inc.
Genentech Access Solutions helps patients access their medicines and explore possible solutions to coverage or reimbursement issues. For patients and their healthcare providers, Genentech Access Solutions provides: coverage and reimbursement, patient assistance, and informational resources. Call (866) 4 ACCESS / (866) 422-2377 between the hours of 6 a.m. and 5 p.m. PST Monday through Friday or 24/7 through our website
www.genentech-access.com/patient.html

Merck & Company, Inc.
Merck Patient Assistance Program
This private and confidential program provides medicine free of charge to eligible individuals, primarily the uninsured.
Telephone: 1-800-727-5400
www.merck.com/merckhelps/patientassistance/home.html

Novartis Pharmaceuticals
Novartis Oncology Reimbursement Program
PAP Enrollment
The Novartis Pharmaceuticals Corporation’s Patient Assistance Program (PAP) provides assistance to patients experiencing financial hardship who have no third party insurance coverage for their medicines.
Telephone: 1-888-669-6682
www.pharma.us.novartis.com/our-products/patient-assistance/patient-assistance-foundation-enrollment

Pfizer
Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings.
Pfizerrxpathways.com

Health and Pharmaceutical Resources
https://www.rxresource.org/index.html

Food and Drug Administration (FDA), Single Patient Investigational New Drug Program
Patients who are not eligible for a clinical trial and who are in an immediate medical crisis may be able to receive drugs that are not yet FDA-approved. Your doctor would have to apply to the FDA for permission to use the drug, an approval known as a Single Patient IND for Compassionate or Emergency Use. Contact information appears below. The FDA usually responds to an application within 24 to 48 hours.
Telephone: CDER Oncology Drug Products (most cancer drugs): 301-594-2473
CBER Oncology Branch (for biologicals): 301-827-5093
www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm107434.htm

National Cancer Institute (NCI)
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that comprise the Department of Health and Human Services (HHS). NCI, established under the National Cancer Institute Act of 1937, is the Federal Government’s principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of NCI and created the National Cancer Program.
https://www.cancer.gov/types/lung